Drugmaker To Pay £8M To NHS To Settle Antitrust Probe

Law360, London (August 14, 2019, 5:20 PM BST) -- A pharmaceuticals company has agreed to pay £8 million ($9.6 million) to the National Health Service for conspiring to drive up drug prices, Britain’s antitrust watchdog said Wednesday — the first such settlement it has secured.

The Competition and Markets Authority said that Aspen, a South African pharmaceuticals company, has agreed to pay £8 million to the health service, as well as a fine of up to £2.1 million, after it took part in a scheme with two other drug companies to restrict the U.K. market for fludrocortisone, a drug used to treat adrenal problems.

The ploy ensured that Aspen was...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS